Combined hepatocellular cholangiocarcinoma: A clinicopathological update

doi:10.4254/wjh.v16.i5.766

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1693)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

HTML

1273

Figures (1-2)

115

Tables (1-3)

120

Sum=1551

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=73

May 27, 2024 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. May 27, 2024; 16(5): 766-775
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.766

Combined hepatocellular cholangiocarcinoma: A clinicopathological update

Mukul Vij, Fadl H Veerankutty, Ashwin Rammohan, Mohamed Rela

Mukul Vij, Department of Pathology, Institute of Liver Disease and Transplantation, Chennai 600044, India

Fadl H Veerankutty, Comprehensive Liver Care Institute, VPS Lakeshore, Cochin 682040, India

Fadl H Veerankutty, Ashwin Rammohan, Mohamed Rela, Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Chennai 600044, India

Author contributions: Veerankutty FH and Vij M conceptualized the study and collected the data and contributed to manuscript preparation; Vij M, Veerankutty FH, Rammohan A and Rela M drafted and edited the manuscript.

Conflict-of-interest statement: There is no conflict of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Fadl H Veerankutty, MBBS, MS, FMAS, DrNB (GI Surgery), Senior Consultant and Program Director, Comprehensive Liver Care Institute, VPS Lakeshore, NH 66, Nettoor, Maradu, Cochin 682040, India. write2drfadl@gmail.com

Received: December 4, 2023
Revised: January 31, 2024
Accepted: April 9, 2024
Published online: May 27, 2024
Processing time: 169 Days and 23.4 Hours

Core Tip

Core Tip: Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) represents a poorly understood rare primary liver tumor with a gruesome prognosis. Molecular and genetic characterization of this disease is vital for exploring newer treatment modalities to improve the survival of patients afflicted with this rare entity. In this review, we give an account of the recent developments in the pathology, diagnostic approach, and management of cHCC-CCA.